Open AccessFBP1 knockdown decreases ovarian cancer formation and cisplatin resistance through EZH2-mediated H3K27me3
Author(s) -
Xifeng Xiong,
Xudong Lai,
Jin-Li Zhang,
Qingqi Meng,
Pengzhen Wang,
Shengnan Qin,
Wei Liu,
Yongxuan Wang,
Zhuo Yao,
Di Wang,
Xiaojian Li,
Zhihe Liu,
Haixiong Miao
Publication year - 2022
Publication title -
bioscience reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.938
H-Index - 77
eISSN - 1573-4935
pISSN - 0144-8463
DOI - 10.1042/bsr20221002
Subject(s) - gene knockdown , ezh2 , cisplatin , cancer research , ovarian cancer , cell growth , chemistry , biology , apoptosis , cancer , epigenetics , genetics , chemotherapy , biochemistry , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom